Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

REVIVA PHARMACEUTICALS HOLDINGS, INC.

(RVPH)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
All news about REVIVA PHARMACEUTICALS HOLDINGS, INC.
09/20REVIVA PHARMACEUTICALS : Shareholder Director Nominations (Form 8-K)
PU
09/20REVIVA PHARMACEUTICALS HOLDINGS, INC : Shareholder Director Nominations (form 8-K)
AQ
09/15Reviva Pharmaceuticals to Present at the UpcomingáBenzinga Healthcare Small Cap Confere..
GL
09/02REVIVA PHARMACEUTICALS : to Present at the H.C. Wainwright 23rd Annual Global Investment C..
AQ
08/16REVIVA PHARMACEUTICALS : Reports Second Quarter 2021 Financial Results and Recent Business..
PU
08/16REVIVA PHARMACEUTICALS HOLDINGS, INC : Results of Operations and Financial Condition, Regu..
AQ
08/16REVIVA PHARMACEUTICALS : Reports Second Quarter 2021 Financial Results and Recent Business..
AQ
08/16Reviva Pharmaceuticals Holdings, Inc. Announces Earnings Results for the Second Quarter..
CI
08/16REVIVA PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND R..
AQ
08/16Reviva Pharmaceuticals Holdings, Inc. Reports Earnings Results for the Second Quarter E..
CI
07/26REVIVA PHARMACEUTICALS : Maxim Group Initiates Reviva Pharmaceuticals at Buy Rating With $..
MT
06/28Reviva Added to Russell Microcap« Index
GL
06/16REVIVA PHARMACEUTICALS HOLDINGS, INC : Change in Directors or Principal Officers (form 8-K..
AQ
05/27Wall Street Sees Narrowly Mixed Open, Q1 GDP Growth Unrevised at 6.4% in Second Estimat..
MT
05/26Reviva Announces Pricing of Upsized $30 Million Underwritten Public Offering
GL
05/17REVIVA PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND R..
AQ
05/17Reviva Pharmaceuticals Holdings, Inc. Reports Earnings Results for the First Quarter En..
CI
05/12REVIVA PHARMACEUTICALS : Results of Operations and Financial Condition (Form 8-K)
PU
05/10REVIVA PHARMACEUTICALS HOLDINGS, INC : Results of Operations and Financial Condition (form..
AQ
05/10Reviva Pharmaceuticals Holdings, Inc. Provides Preliminary Earnings Guidance for the Qu..
CI
05/07REVIVA PHARMACEUTICALS : 10-k/a - management's discussion and analysis of financial condit..
AQ
05/07REVIVA PHARMACEUTICALS HOLDINGS, INC : Results of Operations and Financial Condition, Non-..
AQ
04/26Reviva Announces Full Details of Positive Phase 2 Clinical Trial Results for Acute Schi..
GL
04/26Reviva Pharmaceuticals Holdings, Inc. Announces Full Details of Positive Phase 2 Clinic..
CI
04/15REVIVA PHARMACEUTICALS HOLDINGS, INC : Change in Directors or Principal Officers, Financia..
AQ
03/22REVIVA PHARMACEUTICALS HOLDINGS, INC : Results of Operations and Financial Condition, Regu..
AQ
03/22Reviva Pharmaceuticals Holdings, Inc. Reports 2020 Financial Results and Provides Corpo..
GL
03/22Reviva Pharmaceuticals Holdings, Inc. Announces Earnings Results for the Year Ended Dec..
CI
03/22REVIVA PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND R..
AQ
03/21REVIVA PHARMACEUTICALS HOLDINGS, INC : RVPH) added to S&P TMI Index
CI
03/04REVIVA PHARMACEUTICALS HOLDINGS, INC : Other Events, Financial Statements and Exhibits (fo..
AQ
03/04Reviva Pharmaceuticals to Present at the H.C. Wainwright Global Life Sciences Conferenc..
GL
01/20Reviva Pharmaceuticals Holdings, Inc. Announces Fiscal Year Changes
CI
2020Reviva Pharmaceuticals Holdings, Inc. Announces Management Changes
CI
2020REVIVA PHARMACEUTICALS HOLDINGS, INC : RVPH) added to NASDAQ Composite Index
CI
2020REVIVA PHARMACEUTICALS : Tenzing Acquisition Complete Business Combination
MT
2019Reviva Pharmaceuticals, Inc. Announces Successful Completion of Pre-Ind Meeting with FD..
CI
2017Reviva Pharmaceuticals Announces Successful Completion of IND Meeting With FDA on RP506..
CI
2017Reviva Pharmaceuticals Appoints Bradley Thompson to its Board of Directors
CI
2017Reviva Pharmaceuticals Purav Patel to Its Board of Directors
CI
2016Reviva Pharmaceuticals, Inc. announced that it has received $1.154087 million in fundin..
CI
2016Reviva Pharmaceuticals, Inc. announced that it expects to receive $5 million in funding
CI
Upcoming event on REVIVA PHARMACEUTICALS HOLDINGS, INC.
09/29/21